期刊文献+

外周血核因子-κB及sFas/sFasL活性与心力衰竭严重程度的相关性

Relationship between nuclear factor-κB activation and sFas/sFasL concentration in patients with congestive heart failure
下载PDF
导出
摘要 目的:探讨充血性心力衰竭(CHF)患者外周血单个核细胞(PBMCs)核因子-κB(NF-κB)和血浆sFas/sFasL活性变化的意义。方法:采用ELISA法检测76例CHF患者和30例对照组PBMCs的核蛋白提取物NF-κB和血浆sFas/sFasL的活性,并与患者心功能及超声心动图参数相比较,分析其与心功能及心肌重构的关系。结果:CHF患者PBMCs中NF-κB及血浆sFas/sFasL活性高于对照组,二者与心脏收缩功能相关指标呈显著负相关,与心肌重构相关指标呈显著正相关,并且NF-κB的活化与sFas/sFasL水平呈正相关(P<0.05)。结论:CHF患者NF-κB及sFas/sFasL活性明显增高,并与心功能恶化及心肌重构程度密切相关。 AIM:To investigate the relationship between nuclear factor-κB activation and sFas/sFasL on perpherial blood mononuclear cells in patients with congestive heart failure(CHF).METHODS: Seventy-six patients with CHF and 30 age-and gender-matched healthy subjects were included in the study.Concentrations of sFas/sFasL and activity of NF-κB on peripheral blood mononuclear cells were measured using ELISA assay and were compared with the echocardiographic parameters and cardiac function indexes.RESULTS: Concentrations of sFas/sFasL and NF-κB activity on peripheral blood mononuclear cells in CHF patients were higher than those in control group and in CHF patients.They were negatively correlated with cardiac function indexes but positively correlated with heart remodeling indexes.The activation level of NF-κΒ was positively correlated with the concentrations of sFas/sFasL(P0.05).CONCLUSION: The concentrations of sFas/sFasL and the activity of NF-κB increase in CHF patients and can be used as markers of the development of heart remodeling and heart function failure.
出处 《心脏杂志》 CAS 2012年第6期712-714,718,共4页 Chinese Heart Journal
关键词 心力衰竭 核因子-ΚB SFAS SFASL congestive heart failure nuclear factor-κB sFas sFasL
  • 相关文献

参考文献8

  • 1郭瑞威,杨丽霞.核因子-κB在心力衰竭治疗中的研究进展[J].心血管病学进展,2005,26(3):288-290. 被引量:9
  • 2A Khoynezhad,Z Jalali,AJ Tortolani.A synopsis of research in cardiac apoptosis and its application to congestive heart failure[].Texas Heart Institute Journal.2007
  • 3Ibe W,Saraste A,Lindemann S,et al.Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodeling in dilated cardiomyopathy,but is not affected by growth hormone treatment[].European Journal of Heart Failure.2007
  • 4BlancoColin LM,MartinVentum JL,de Teresa E,et al.Increased solubleFas p lasma levels in subject at high cardiovascular risk:Atorvastain oninflammatory markers (AM) study, a study of ACT2FAST[].Arteriosclerosis Thrombosis and Vascular Biology.2007
  • 5Okamoto T,,Sakurada S,Yang JP,et al.Regulation of NF-kappa B and disease control:identification of a novel serine ki-nase and thioredoxin as effector for signal transduction pathway for NFκB activation[].Current Topics in Cellular Regulation.1997
  • 6Setsuta,K,Seino,Y,Ogawa,T,Ohtsuka,T,Seimiya,K,Takano,T.Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system[].Circulation Journal.2004
  • 7Nadzhafipur R,Dolgov VV,Orlova OV et al.Markers of Fas-mediated apoptosis in patients with heart failure.[].Klinicheskaia Laboratornaia Diagnostika.2007
  • 8Starace D,Riccioli A,D’’Alessio A,et al.Characterization of signa-ling pathways leading to Fas expression induced by TNF-alpha:piv-otal role of NF-kappaB[].The FASEB Journal.2005

二级参考文献18

  • 1Matsushita H,Morishita R,Nata T,et al.Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB(NF-kappaB)-mediated bcl-2 suppression:in vivo evidence of the importance of NF-kappaB in endothelial cell regulation[J].Circ Res,2000,86(9):974-981.
  • 2Greenberg BJ.Treatment of heart failure:state of the art and prospectives[J].Cardiovasc Pharmacol,2001,38:59-63.
  • 3Hasegawa K,Iwaikansi E,Sasayama S.Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure[J].J Cell Physiol,2001,186:11-18.
  • 4Frantz S,Fraccarllo D,Wagner H,et al.Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure[J].Cardiovasc Res,2003,57:749-756.
  • 5Matsumori A.Anti-inflammatory therapy for heart failure[J].Current Opinion in Pharmacology,2004,4:1-6.
  • 6Matsumori A,Sasayama S.The role of inflammatory mediators in the failingheart:immunomodulation of cytokines in experimental models of heart failure [J].Heart Fail Rev,2001,6(2):129-136.
  • 7The EPOCH Study Group:Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure--the effects of pimobendan on chronic heart failure study(EPOCH study)[J].Circulation,2002,66:149-157.
  • 8Chanani NK,Cowan DB,Takeuchi K,et al.Differential effects of amrinone and milrinone upon myocardial inflammatory signaling[J].Circulation,2002,106:I284-I289.
  • 9Singh H,Sen R,Baltimore D,et al.A nuclear factor that binds to a conserved sequence motive in transcriptional control elements of immunoglobuling genes[J].Nature,1986,319(6049):154-158.
  • 10Finco TS,Baldwin AS.Mechanistic aspects of NF-κB regulation:the emerging role of phosphorylation and proteolysis[J].Immunity,1995,3:263-272.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部